Investigating the Mechanisms and Therapeutic Applications of Chalcones
Keywords:
Chalcones, therapeutic efficacy, mechanisms, analgesic activityAbstract
Introduction: Chalcones, are a group of organic compounds containing two aromatic rings bridged by a three-carbon -a,
?; unsaturated carbonyl system. This attracted much attention because of their versatility in pharmacological profiles.
Aims & Objectives: To investigate the therapeutic efficacy of a particular chalcone derivative, namely (E)-1-(4- bromophenyl)-3-(4-chlorophenyl) prop-2-ene-1-one.
Place and Duration of Study: It was conducted in the Pharmacology Laboratory of the Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, and the University of Malakand for about one year.
Material & Method: This was a lab-based experimental study. The therapeutic efficacy of a chalcone derivative, (E)-1- (4-bromophenyl)-3-(4-chlorophenyl) prop-2-ene-1-one was assessed through an experiment on pain and inflammation in mice. Claisen-Schmidt condensation reaction and spectroscopic tools were used.
Results: Pharmacological data proved a significant decrease in pain and inflammation as compared to Diclofenac Sodium. Reduction of 75.20% in acetic acid-induced writhing as compared to 84.4% with Diclofenac. After 3 hours, there was 67.08% reduction in edema.
Conclusion: This study provides evidence that chalcone derivatives in moderation may be effective and safer than present-day drugs that address pain and inflammation. This result may need to be further clinically related to potentially translate them in different patient populations in terms of efficacy and safety.
References
Zhang Y, Zhang W, Wang Q, Xing J. Recent advances in the anti-cancer effects of chalcones. Bioorg Med Chem. 2020;28(2):115240. doi:10.1016/j.bmc.2019.115240
Singh P, Singh R, Bhardwaj V, Sharma M, Kumar A. Chalcones: A promising anticancer scaffold. J Mol Struct. 2021;1225:129184. doi:10.1016/j.molstruc.2020.129184
Kumar S, Kumar A, Sharma M, Pandey AK. Pharmacological activities of chalcones: A review. Chem Biol Drug Des. 2022;99(2):140-155. doi:10.1111/cbdd.14026
Thapa P, Lee YR. Anticancer and antioxidant effects of natural and synthetic chalcones. Molecules. 2019;24(5):756. doi:10.3390/molecules24050756
Ali I, Lone MN, Aboul-Enein HY. Recent advances in synthetic chalcones as anticancer agents. Med Res Rev. 2020;40(5):1795-1821. doi:10.1002/med.21668
Kumar V, Sharma M, Kumari P, Saini N, Verma M, Bhatia R. Structural modifications in chalcone derivatives: potential anticancer agents. Med Chem Res. 2021;30(7):1411-1426. doi:10.1007/s00044-021-02702-7
Rai R, Prakash O, Yadav VK, Tripathi CKM. Chalcones: Promising molecules for anticancer drug discovery. Future Med Chem. 2020;12(19):1737-1762. doi:10.4155/fmc-2020-0065
García A, García-Vilas JA, Quesada AR, Medina MÁ. Anti-angiogenic activity of chalcones in experimental models: promising results for cancer therapy. Chem Biol Interact. 2021;339:109291. doi:10.1016/j.cbi.2020.109291
Singh VK, Yadav R, Tripathi A, Kumar S, Kushwaha HN. Recent developments in the pharmacological profile of chalcones: A systematic review. Eur J Med Chem. 2023;239:114709. doi:10.1016/j.ejmech.2022.114709
Al-Othman ZA, Al-Warthan AA, Ali I. Recent progress of chalcones as potential therapeutic agents: A review. Expert Opin Ther Pat. 2019;29(9):697-711. doi:10.1080/13543776.2019.1648588
da Cunha Xavier J, de Almeida-Neto FW, Rocha JE, Freitas TS, Freitas PR, de Araujo AC, et al. Spectroscopic analysis by NMR, FT-Raman, ATR-FTIR, and UV-Vis, evaluation of antimicrobial activity, and in silico studies of chalcones derived from 2-hydroxyacetophenone. J Mol Struct. 2021;1241:130647. doi:10.1016/j.molstruc.2021.130647
Vaghela JH, Shah JH, Patel JH, Purohit BM. Comparison of safety and analgesic efficacy of diclofenac sodium with etodolac after surgical extraction of third molars: a randomized, double-blind, double-dummy, parallel-group study. J Dent Anesth Pain Med. 2020;20(1):19-27. doi:10.17245/jdapm.2020.20.1.19
Cuesta SA, Meneses L. The role of organic small molecules in pain management. Molecules. 2021;26(13):4029. doi:10.3390/molecules26134029
Fouad AI, Alqarni MH, Devi S, Singh A, Alam A, Alam P, et al. Analgesic action of catechin on chronic constriction injury-induced neuropathic pain in Sprague–Dawley rats. Front Pharmacol. 2022;13:895079. doi:10.3389/fphar.2022.895079
Ou Z, Zhao J, Zhu L, Huang L, Ma Y, Ma C, et al. Anti-inflammatory effect and potential mechanism of betulinic acid on ?-carrageenan-induced paw edema in mice. Biomed Pharmacother. 2019;118:109347. doi:10.1016/j.biopha.2019.109347
Hoxha M. What about COVID-19 and arachidonic acid pathway? Eur J Clin Pharmacol. 2020;76:1501-1504. doi:10.1007/s00228-020-02920-6
Malafoglia V, Ilari S, Vitiello L, Tenti M, Balzani E, Muscoli C, et al. The interplay between chronic pain, opioids, and the immune system. Neuroscientist. 2022;28(6):613-627. doi:10.1177/10738584211060135
Dan W, Dai J. Recent developments of chalcones as potential antibacterial agents in medicinal chemistry. Eur J Med Chem. 2020;187:111980. doi:10.1016/j.ejmech.2019.111980
Rudrapal M, Khan J, Dukhyil AA, Alarousy RM, Attah EI, Sharma T, et al. Chalcone scaffolds, bio precursors of flavonoids: Chemistry, bioactivities, and pharmacokinetics. Molecules. 2021;26(23):7177. doi:10.3390/molecules26237177
Su CM, Wang L, Yoo D. Activation of NF-?B and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2. Sci Rep. 2021;11(1):13464. doi:10.1038/s41598-021-92869-5
Zhang YL, Zhang WX, Yan JQ, Tang YL, Jia WJ, Xu ZW, et al. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2. Acta Pharmacol Sin. 2022;43(1):76-85. doi:10.1038/s41401-021-00530-y
Guazelli CF, Fattori V, Ferraz CR, Borghi SM, Casagrande R, Baracat MM, et al. Antioxidant and anti-inflammatory effects of hesperidin methyl chalcone in experimental ulcerative colitis. Chem Biol Interact. 2021;333:109315. doi:10.1016/j.cbi.2021.109315
Mahesha P, Shetty NS. Naphthyl–based chalcone derivatives: A multifaceted player in medicinal chemistry. ChemistrySelect. 2024;9(19). doi:10.1002/slct.202400522
Siddiqa A, Tajammal A, Irfan A, Azam M, Munawar MA, Hardy RS, et al. Synthesis, molecular docking, bio-evaluation, and quantitative structure-activity relationship of new chalcone derivatives as antioxidants. J Mol Struct. 2023;1277:134814. doi:10.1016/j.molstruc.2023.134814
Al-ghulikah HA, Mughal EU, Elkaeed EB, Naeem N, Nazir Y, Alzahrani AY, et al. Discovery of chalcone derivatives as potential ?-glucosidase and cholinesterase inhibitors: Effect of hyperglycemia in paving a path to dementia. J Mol Struct. 2023;1275:134658. doi:10.1016/j.molstruc.2023.134658
Afridi HH, Shoaib M, Al-Joufi FA, Shah SW, Hussain H, Ullah A, et al. Synthesis and investigation of the analgesic potential of enantiomerically pure schiff bases: A mechanistic approach. Molecules. 2022;27(16):5206. doi:10.3390/molecules27165206
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Proceedings
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a 